Alliance Pharma PLC banner
A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 64.7 GBX
Market Cap: £356.5m

Alliance Pharma PLC
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Alliance Pharma PLC
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
A
Alliance Pharma PLC
LSE:APH
Other
-£8.8m
CAGR 3-Years
-44%
CAGR 5-Years
-18%
CAGR 10-Years
-24%
GlaxoSmithKline PLC
LSE:GSK
Other
-£1B
CAGR 3-Years
N/A
CAGR 5-Years
12%
CAGR 10-Years
-3%
AstraZeneca PLC
LSE:AZN
Other
-$70m
CAGR 3-Years
59%
CAGR 5-Years
7%
CAGR 10-Years
-3%
Hikma Pharmaceuticals PLC
LSE:HIK
Other
-$94m
CAGR 3-Years
-7%
CAGR 5-Years
-23%
CAGR 10-Years
-13%
Allergy Therapeutics PLC
LSE:AGY
Other
-£1.9m
CAGR 3-Years
-52%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Animalcare Group PLC
LSE:ANCR
Other
-£2.5m
CAGR 3-Years
-76%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
No Stocks Found

Alliance Pharma PLC
Glance View

Market Cap
356.5m GBX
Industry
Pharmaceuticals

Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).

APH Intrinsic Value
101.44 GBX
Undervaluation 36%
Intrinsic Value
Price
A

See Also

What is Alliance Pharma PLC's Other?
Other
-8.8m GBP

Based on the financial report for Dec 31, 2024, Alliance Pharma PLC's Other amounts to -8.8m GBP.

What is Alliance Pharma PLC's Other growth rate?
Other CAGR 10Y
-24%

Over the last year, the Other growth was 18%. The average annual Other growth rates for Alliance Pharma PLC have been -44% over the past three years , -18% over the past five years , and -24% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett